Cargando…
Aspirin for Primary Prevention of Cardiovascular Diseases: “WALTZ” with the Evidence
PURPOSE OF REVIEW: In this review article, a detailed analysis of the current literature is provided, along with a “glimpse” into what the future holds for aspirin in the context of primary prevention. RECENT FINDINGS: The role of aspirin in primary prevention of cardiovascular diseases (CVD) has be...
Autores principales: | Dimitriadis, Kyriakos, Lazarou, Emilia, Tsioufis, Panagiotis, Soulaidopoulos, Stergios, Tsioufis, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297059/ https://www.ncbi.nlm.nih.gov/pubmed/35857202 http://dx.doi.org/10.1007/s11886-022-01740-2 |
Ejemplares similares
-
COVID-19 and Cardiovascular Disease: a Global Perspective
por: Pina, Alessandra, et al.
Publicado: (2021) -
Influenza Vaccination for Cardiovascular Prevention: Further Insights from the IAMI Trial and an Updated Meta-analysis
por: Maniar, Yash M., et al.
Publicado: (2022) -
Omega-3 Fatty Acids and Cardiovascular Disease: Are There Benefits?
por: Bowen, Kate J., et al.
Publicado: (2016) -
Aging Hearts in a Hotter, More Turbulent World: The Impacts of Climate Change on the Cardiovascular Health of Older Adults
por: Chang, Andrew Y., et al.
Publicado: (2022) -
Intersection Between Diabetes and Heart Failure: Is SGLT2i the “One Stone for Two Birds” Approach?
por: Zhang, Qing, et al.
Publicado: (2021)